NPPB and COVID-19: In noncritically ill patients with COVID-19, markers for inflammation and cardiac biomarkers were predictive of post-acute COVID-19 (monocyte-to-lymphocyte ratio; NT-pro BNP) and 30-day mortality (neutrophil-to-lymphocyte ratio; NT-pro BNP) [19].